Antibiotice Iasi reports 24% increase in 2023 turnover

 Medicine maker Antibiotice Iasi reported a 24% increase in net turnover on the domestic and international market, from 484 million RON (2022) up to 601 million RON in 2023, and a net profit of 82.2 million RON, higher than the previous year, according to a company's release."From the total turnover related to 2023, the value of sales on the Romanian market was 382.4 million RON, 28% higher compared to the value achieved in the previous year. The ...

Developed by Codecraftsman